{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:56:25Z","timestamp":1777589785311,"version":"3.51.4"},"reference-count":28,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,9,12]]},"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:p>A woman in her 50s presented to the hospital with new-onset jaundice and ascites. Her medical history included a melanoma of the right shoulder, diagnosed 8 months before, for which she had received four cycles of ipilimumab and nivolumab. Due to the oncological history and previous immunotherapy, an immune-checkpoint-inhibitor (ICI)-induced hepatitis was suspected, and a high-dose corticosteroid treatment was initiated. However, as there was no improvement in the liver function tests, a percutaneous liver biopsy was performed for further diagnostic clarification. Histological analysis ultimately identified a hepatic sinusoidal obstruction syndrome (SOS) as the underlying cause of liver dysfunction and portal hypertension. ICI-related hepatic SOS represents an extremely rare adverse event related to immunotherapy that should be considered in all patients with treatment-refractory ICI-related hepatotoxicity and clinical signs of portal hypertension.<\/jats:p>","DOI":"10.1136\/bcr-2024-260066","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T14:45:14Z","timestamp":1727707514000},"page":"e260066","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Hepatic sinusoidal obstruction syndrome after immune-checkpoint-inhibitor therapy: when the liver sends SOS"],"prefix":"10.1136","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6218-2239","authenticated-orcid":false,"given":"Philipp","family":"Kasper","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Hospital Cologne, Cologne, North Rhine-Westphalia, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Kristin","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital Cologne, Cologne, North Rhine-Westphalia, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Christoph","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Hospital Cologne, Cologne, North Rhine-Westphalia, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"2025082702072932000_17.9.e260066.1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31227"},{"key":"2025082702072932000_17.9.e260066.2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00489","article-title":"Diagnosis and Treatment of VOD\/SOS After Allogeneic Hematopoietic Stem Cell Transplantation","volume":"11","author":"Bonifazi","year":"2020","journal-title":"Front Immunol"},{"key":"2025082702072932000_17.9.e260066.3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)","volume":"58","author":"Mohty","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"2025082702072932000_17.9.e260066.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2014.10.002"},{"key":"2025082702072932000_17.9.e260066.5","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000001038","article-title":"Cemiplimab-Associated Sinusoidal Obstruction Syndrome","volume":"10","author":"Sarsour","year":"2023","journal-title":"ACG Case Rep J"},{"key":"2025082702072932000_17.9.e260066.6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321299"},{"key":"2025082702072932000_17.9.e260066.7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22007"},{"key":"2025082702072932000_17.9.e260066.8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22056"},{"key":"2025082702072932000_17.9.e260066.9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JOP.19.00276","article-title":"SOS! Immunotherapy-Associated Sinusoidal Obstructive Syndrome","volume":"15","author":"Ho","year":"2019","journal-title":"J Oncol Pract"},{"key":"2025082702072932000_17.9.e260066.10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.15403\/jgld-3207","article-title":"Hepatic sinusoidal obstruction syndrome associated with nivolumab: an uncommon adverse event related to immune checkpoint inhibitors","volume":"30","author":"Riveiro-Barciela","year":"2021","journal-title":"J Gastrointestin Liver Dis"},{"key":"2025082702072932000_17.9.e260066.11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.annonc.2020.02.004","article-title":"Hepatic sinusoidal obstruction syndrome induced by nivolumab in advanced melanoma: a case report","volume":"31","author":"Charvet","year":"2020","journal-title":"Ann Oncol"},{"key":"2025082702072932000_17.9.e260066.12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41409-019-0705-z","article-title":"Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a position statement from an international expert group","volume":"55","author":"Mohty","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"2025082702072932000_17.9.e260066.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.09.012"},{"key":"2025082702072932000_17.9.e260066.14","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N"},{"key":"2025082702072932000_17.9.e260066.15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbmt.2013.10.014","article-title":"Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study","volume":"20","author":"Ruutu","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025082702072932000_17.9.e260066.16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-2005-858957","article-title":"TIPS for veno-occlusive disease following stem cell transplantation","volume":"44","author":"Schoppmeyer","year":"2006","journal-title":"Z Gastroenterol"},{"key":"2025082702072932000_17.9.e260066.17","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2001.210105.x"},{"key":"2025082702072932000_17.9.e260066.18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702386"},{"key":"2025082702072932000_17.9.e260066.19","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2023.01.118","article-title":"Clinical impact and treatment of veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS) after liver transplant (LT). The role of transjugular intrahepatic porto-systemic shunt (TIPS)","volume":"55","author":"Triolo","year":"2023","journal-title":"Dig Liver Dis"},{"key":"2025082702072932000_17.9.e260066.20","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.bbmt.2020.08.006","article-title":"Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease\/Sinusoidal Obstruction Syndrome (VOD\/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide","volume":"26","author":"G\u00f3mez-Centuri\u00f3n","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025082702072932000_17.9.e260066.21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/bjh.14727","article-title":"Earlier defibrotide initiation post-diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation","volume":"178","author":"Richardson","year":"2017","journal-title":"Br J Haematol"},{"key":"2025082702072932000_17.9.e260066.22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2024.01.046","article-title":"Pembrolizumab-Induced Liver Injury: Beyond Immune-Mediated Hepatitis","volume":"167","author":"Herms","year":"2024","journal-title":"Gastroenterology"},{"key":"2025082702072932000_17.9.e260066.23","doi-asserted-by":"crossref","unstructured":"Diego Q , Thomas S , Mathieu G , et al . Orthotopic Liver Transplantation for Treatment of Sinusoidal Obstruction Syndrome: A Case Report. J Transplant Surg 2018;1. doi:10.36959\/338\/327","DOI":"10.36959\/338\/327"},{"key":"2025082702072932000_17.9.e260066.24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1034\/j.1600-6143.2002.20815.x","article-title":"A successful liver transplantation for refractory hepatic veno-occlusive disease originating from cord blood transplantation","volume":"2","author":"Kim","year":"2002","journal-title":"Am J Transplant"},{"key":"2025082702072932000_17.9.e260066.25","article-title":"Living Donor Liver Transplantation for Hepatic Venoocclusive Disease\/Sinusoidal Obstruction Syndrome Originating from Hematopoietic Stem Cell Transplantation","volume":"2022","author":"Ichimura","year":"2022","journal-title":"Case Rep Transplant"},{"key":"2025082702072932000_17.9.e260066.26","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101619","article-title":"The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity","volume":"28","author":"Xing","year":"2023","journal-title":"Transl Oncol"},{"key":"2025082702072932000_17.9.e260066.27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/HEP.0000000000000045","article-title":"Checkpoint inhibitor hepatotoxicity: pathogenesis and management","volume":"79","author":"Cunningham","year":"2024","journal-title":"Hepatology"},{"key":"2025082702072932000_17.9.e260066.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.001"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-260066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:07:40Z","timestamp":1756285660000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-260066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,30]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1136\/bcr-2024-260066"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-260066","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}